These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 4435614

  • 1. [Treatment of parkinsonism by L-dopa and dopa-decarboxylase inhibitor in a single tablet].
    Sarova-Pinhas I, Braham J.
    Harefuah; 1974 Sep 01; 87(5):208-10. PubMed ID: 4435614
    [No Abstract] [Full Text] [Related]

  • 2. L-dopa-carbidopa: combined therapy for the treatment of Parkinson's disease.
    Celesia GG, Wanamaker WM.
    Dis Nerv Syst; 1976 Mar 01; 37(3):123-5. PubMed ID: 1253661
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.
    Pahwa R, Koller WC.
    Adv Neurol; 1996 Mar 01; 69():487-91. PubMed ID: 8615169
    [No Abstract] [Full Text] [Related]

  • 6. [Development of studies on the treatment of parkinsonian syndromes with levodopa. II. Long-term effects of L-DOPA alone or in combination with a decarboxylase inhibitor].
    Rabadeau Dumas JL, Rondot P, Cardon P.
    Therapie; 1977 Mar 01; 32(2):161-72. PubMed ID: 898124
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Decarboxylase inhibitors combined with L-dopa in the treatment of Parkinson's disease].
    Rondot P.
    Rev Prat; 1974 Mar 11; 24(15):1211-2, 1215-6, 1219. PubMed ID: 4416964
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [L-DOPA-and dopa-decarboxylase inhibitor combination for the treatment of Parkinsonism].
    Fujimori N, Kito S, Yamamoto M, Itoga E, Kosaka K.
    Nihon Rinsho; 1974 Mar 11; 32(3):579-86. PubMed ID: 4859014
    [No Abstract] [Full Text] [Related]

  • 13. Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's disease.
    Brannan T, Yahr MD.
    Ann Neurol; 1995 Jan 11; 37(1):95-8. PubMed ID: 7818264
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The combination of L-dopa and carbidopa in therapy of a case of familial juvenile parkinsonism].
    Piccirilli M, Piccinin GL, La Medica A.
    Clin Ter; 1981 Feb 15; 96(3):335-40. PubMed ID: 7307449
    [No Abstract] [Full Text] [Related]

  • 17. Recent advances in the treatment of Parkinson's disease.
    Martocci RJ.
    J Am Osteopath Assoc; 1975 Apr 15; 74(8):730-41. PubMed ID: 1092751
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor].
    Christiani K, Möller WD.
    Munch Med Wochenschr; 1973 Apr 20; 115(16):711-3. PubMed ID: 4197759
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical significance of cramps of the lower extremities in patients with parkinsonism].
    Yu HZ.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug 20; 18(4):217-8. PubMed ID: 4075911
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.